For lung cancer screening, outcomes were receipt of LDCT (CPT codes G0297, S8032, 71271) in enrollees who had not had a chest CT in the prior 11 months.23 Chest CTs were identified by CPT/ HCPCS codes (G0297, S8032, 71271, 71250, 71260, 71270) or ICD-10-CM codes BW2400Z, BW...
If screening had no effect on quit rates, annual screening costs more but provided fewer QALYs than annual cessation therapies. Annual combined screening/cessation therapy programs at age 50 years costs $130,500 to $159,700/QALY, when compared with annual stand-alone cessation. Conclusions The ...
King et al (2009) examined the relationship between BOS and GERD measured by esophageal impedance. After the initiation of routine screening for GERD, 59 LTX recipients underwent ambulatory esophageal impedance monitoring. Exposure to acid reflux and non-acid liquid reflux was recorded. Clinical outcom...
Eddy DM: Screening for lung cancer. Ann Intern Med 1989,111:232–237. Article PubMed CAS Google Scholar Karp D, Mulshine J, Henschke C, et al.: Non-small-cell lung cancer: screening, new imaging and prevention. Am Soc Clin Oncol Educational Book; 587–501, 2000. Google Scholar Hens...
Sanger sequencing was performed for genotypic screening of selected cell colonies, and immunoblots were performed to confirm the depletion of CPT1a in MLE12 cells. The control MLE12 cell was generated through the transduction of the lentiCRISPRv2 vector. MLE12 cells with CPT1a-Myc-DDK fusion ...
Concurrent and mutual exclusion analysis indicated that EML4-ALK fusion was mutually exclusive with EGFR mutations (Supplementary Fig. 12), consistent with a recent large-scale clinical screening of NSCLC for EGFR, KRAS mutations and ALK rearrangements38. Previously reported rearrangements of ROS1 and ...
little is known about its role in AT2 cell biology and function. Downregulation of CPT1a in AT2 cells has been implicated in a murine model of acute lung injury23, and the ratio of carnitine to palmitoylcarnitine plus oleylcarnitine [C0/(C16 + C18)], an indicator of CPT1 deficiency,...
Screening for SARS-CoV-2-specific mAbs was done by using anti-SARS-CoV-2-S1 IgG ELISAs (EUROIMMUN Medizinische Labordiagnostika AG) according to the manufacturer’s protocol. mAb containing cell culture supernatants were pre-diluted 1:5, patient sera 1:100. Optical density (OD) ratios were ca...
Histopathological scores, BALF cell counts and metabolite screening were assessed. Multivariate and univariate analyses were performed. Profound histological, cellular, and metabolic changes were identified in all patients after CPB. Histological and cellular changes were similar in the three groups; however...
All SectionsCancer BiomarkersCancer Causes, Screening and DiagnosisCancer Drug DevelopmentCancer Epidemiology and PreventionCancer Immunology and ImmunotherapyCancer Informatics and Big DataCancer MetastasisCancer PathophysiologyCancer Survivorship and Quality of LifeCancer TherapyClinical Research of CancerInfectious Ag...